Sarepta Therapeutics, Inc. SRPT Business Segments — Investment Income Interest
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sarepta Therapeutics, Inc.'s business segments — investment income interest.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Sarepta Therapeutics, Inc.'s business segments — investment income interest?
- Sarepta Therapeutics, Inc. (SRPT) reported business segments — investment income interest of -$6.36M in Q1 2026.
- How has Sarepta Therapeutics, Inc.'s business segments — investment income interest changed year-over-year?
- Sarepta Therapeutics, Inc.'s business segments — investment income interest increased by 37.6% year-over-year, from -$10.19M to -$6.36M.
- What does business segments — investment income interest mean?
- Income generated from interest-bearing financial instruments or cash equivalents held by the segment. This reflects the segment's ability to earn returns on its idle cash or short-term investments. It serves as a non-operating contributor to the segment's overall financial health.